Preventice Solutions delivers digital healthcare solutions and remote cardiac monitoring services using deep learning and AI. Its product portfolio includes the cloud-based PatientCare subscription platform, the BodyGuardian® MINI family of monitors (covering short- and long-term Holter, cardiac event monitoring and mobile cardiac telemetry) and the BeatLogic® analytics engine. Preventice reports over a decade of experience, having monitored millions of patients and supporting thousands of practices nationwide. In May 2020 the company published Heart Rhythm Journal data showing BeatLogic outperformed leading algorithms on AFib and VEB classification in MIT datasets. The company plans to use new capital to accelerate salesforce expansion, invest in technology and product innovation, and further develop clinical evidence for its flagship solutions. Preventice emphasizes integration with physicians, payers and Integrated Delivery Networks through PatientCare and electronic medical record integration capabilities. Preventice Solutions develops mobile health monitoring technologies and services that connect patients and caregivers. Its product portfolio includes the PatientCare Platform and the BodyGuardian® range — BodyGuardian® Heart, BodyGuardian® Verité and BodyGuardian® Holter. The company is led by co-CEOs Jon Otterstatter (President and Chief Global Strategy Officer) and John Untereker (Executive Vice President and Chief Operating Officer). Preventice received an equity investment from Boston Scientific. As part of the arrangement, Boston Scientific will become the exclusive worldwide sales and marketing representative for cardiology-related diagnostic and monitoring offerings, indicating a strategic commercial partnership and go-to-market plan. The company is based in Minneapolis, MN.

Total raised

$137M

Funding rounds

2

Latest round

Series B

Latest activity

Jul 2020